@glente.bsky.social
Tired of #chatGPT?
Really fond of the new LLM / chatbot from #Mistral: chat.mistral.ai/chat
It is fast and actually gives some good references to support claims.
The free version is very functional = easy to test.
And it is even based in the #EU so data protection is much better :)
Really fond of the new LLM / chatbot from #Mistral: chat.mistral.ai/chat
It is fast and actually gives some good references to support claims.
The free version is very functional = easy to test.
And it is even based in the #EU so data protection is much better :)
Le Chat - Mistral AI
Chat with Mistral AI's cutting edge language models.
chat.mistral.ai
March 4, 2025 at 11:46 PM
Tired of #chatGPT?
Really fond of the new LLM / chatbot from #Mistral: chat.mistral.ai/chat
It is fast and actually gives some good references to support claims.
The free version is very functional = easy to test.
And it is even based in the #EU so data protection is much better :)
Really fond of the new LLM / chatbot from #Mistral: chat.mistral.ai/chat
It is fast and actually gives some good references to support claims.
The free version is very functional = easy to test.
And it is even based in the #EU so data protection is much better :)
Reposted
📅 Learn how to approach genetic testing for inherited hemostasis disorders, evaluate the pros and cons of different testing types, appropriately match patients with available testing, & interpret their results.
🔗https://bit.ly/401BkfG #HemeSky #BloodSky #Hematology @juliperezbot.bsky.social
🔗https://bit.ly/401BkfG #HemeSky #BloodSky #Hematology @juliperezbot.bsky.social
January 13, 2025 at 12:21 PM
📅 Learn how to approach genetic testing for inherited hemostasis disorders, evaluate the pros and cons of different testing types, appropriately match patients with available testing, & interpret their results.
🔗https://bit.ly/401BkfG #HemeSky #BloodSky #Hematology @juliperezbot.bsky.social
🔗https://bit.ly/401BkfG #HemeSky #BloodSky #Hematology @juliperezbot.bsky.social
@bmj.com: Following 132,542 individuals for up to 27 years, we found that #HFE C282Y #hemochromatosis increases #diabetes risk (even with normal ferritin/TSAT) and nearly doubles diabetes-related mortality. Guidelines need update?
www.bmj.com/content/387/...
www.bmj.com/content/387/...
Mortality and risk of diabetes, liver disease, and heart disease in individuals with haemochromatosis HFE C282Y homozygosity and normal concentrations of iron, transferrin saturation, or ferritin: pro...
Objectives To test whether haemochromatosis HFE C282Y homozygotes have increased risk of diabetes, liver disease, and heart disease even when they have normal plasma iron, transferrin saturation, or f...
www.bmj.com
December 13, 2024 at 7:08 AM
@bmj.com: Following 132,542 individuals for up to 27 years, we found that #HFE C282Y #hemochromatosis increases #diabetes risk (even with normal ferritin/TSAT) and nearly doubles diabetes-related mortality. Guidelines need update?
www.bmj.com/content/387/...
www.bmj.com/content/387/...